HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.

HPV typing using formalin fixed paraffin embedded (FFPE) cervical tissue is used to evaluate HPV vaccine impact, but DNA yield and quality in FFPE specimens can negatively affect test results. This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens...

Full description

Bibliographic Details
Main Authors: Susan Hariri, Martin Steinau, Allen Rinas, Julia W Gargano, Christina Ludema, Elizabeth R Unger, Alicia L Carter, Kathy L Grant, Melanie Bamberg, James E McDermott, Lauri E Markowitz, Noel T Brewer, Jennifer S Smith
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3315505?pdf=render
id doaj-8d547a43316c43ed85078ae33ffc02ac
record_format Article
spelling doaj-8d547a43316c43ed85078ae33ffc02ac2020-11-25T01:48:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3404410.1371/journal.pone.0034044HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.Susan HaririMartin SteinauAllen RinasJulia W GarganoChristina LudemaElizabeth R UngerAlicia L CarterKathy L GrantMelanie BambergJames E McDermottLauri E MarkowitzNoel T BrewerJennifer S SmithHPV typing using formalin fixed paraffin embedded (FFPE) cervical tissue is used to evaluate HPV vaccine impact, but DNA yield and quality in FFPE specimens can negatively affect test results. This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens.Four large North Carolina pathology laboratories provided FFPE specimens from 299 women ages18 and older diagnosed with cervical disease from 2001 to 2006. For each woman, one diagnostic block was selected and unstained serial sections were prepared for DNA typing. Extracts from samples with residual lesion were used to detect and type HPV using parallel and serial testing algorithms with the Linear Array and LiPA HPV genotyping assays.LA and LiPA concordance was 0.61 for detecting any high-risk (HR) and 0.20 for detecting any low-risk (LR) types, with significant differences in marginal proportions for HPV16, 51, 52, and any HR types. Discordant results were most often LiPA-positive, LA-negative. The parallel algorithm yielded the highest prevalence of any HPV type (95.7%). HR type prevalence was similar using parallel (93.1%) and serial (92.1%) approaches. HPV16, 33, and 52 prevalence was slightly lower using the serial algorithm, but the median number of HR types per woman (1) did not differ by algorithm. Using the serial algorithm, HPV DNA was detected in >85% of invasive and >95% of pre-invasive lesions. The most common type was HPV16, followed by 52, 18, 31, 33, and 35; HPV16/18 was detected in 56.5% of specimens. Multiple HPV types were more common in lower grade lesions.We developed an efficient algorithm for testing and reporting results of two commercial assays for HPV detection and typing in FFPE specimens, and describe HPV type distribution in pre-invasive and invasive cervical lesions in a state-based sample prior to HPV vaccine introduction.http://europepmc.org/articles/PMC3315505?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Susan Hariri
Martin Steinau
Allen Rinas
Julia W Gargano
Christina Ludema
Elizabeth R Unger
Alicia L Carter
Kathy L Grant
Melanie Bamberg
James E McDermott
Lauri E Markowitz
Noel T Brewer
Jennifer S Smith
spellingShingle Susan Hariri
Martin Steinau
Allen Rinas
Julia W Gargano
Christina Ludema
Elizabeth R Unger
Alicia L Carter
Kathy L Grant
Melanie Bamberg
James E McDermott
Lauri E Markowitz
Noel T Brewer
Jennifer S Smith
HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
PLoS ONE
author_facet Susan Hariri
Martin Steinau
Allen Rinas
Julia W Gargano
Christina Ludema
Elizabeth R Unger
Alicia L Carter
Kathy L Grant
Melanie Bamberg
James E McDermott
Lauri E Markowitz
Noel T Brewer
Jennifer S Smith
author_sort Susan Hariri
title HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
title_short HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
title_full HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
title_fullStr HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
title_full_unstemmed HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
title_sort hpv genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial dna assays, north carolina, 2001-2006.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description HPV typing using formalin fixed paraffin embedded (FFPE) cervical tissue is used to evaluate HPV vaccine impact, but DNA yield and quality in FFPE specimens can negatively affect test results. This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens.Four large North Carolina pathology laboratories provided FFPE specimens from 299 women ages18 and older diagnosed with cervical disease from 2001 to 2006. For each woman, one diagnostic block was selected and unstained serial sections were prepared for DNA typing. Extracts from samples with residual lesion were used to detect and type HPV using parallel and serial testing algorithms with the Linear Array and LiPA HPV genotyping assays.LA and LiPA concordance was 0.61 for detecting any high-risk (HR) and 0.20 for detecting any low-risk (LR) types, with significant differences in marginal proportions for HPV16, 51, 52, and any HR types. Discordant results were most often LiPA-positive, LA-negative. The parallel algorithm yielded the highest prevalence of any HPV type (95.7%). HR type prevalence was similar using parallel (93.1%) and serial (92.1%) approaches. HPV16, 33, and 52 prevalence was slightly lower using the serial algorithm, but the median number of HR types per woman (1) did not differ by algorithm. Using the serial algorithm, HPV DNA was detected in >85% of invasive and >95% of pre-invasive lesions. The most common type was HPV16, followed by 52, 18, 31, 33, and 35; HPV16/18 was detected in 56.5% of specimens. Multiple HPV types were more common in lower grade lesions.We developed an efficient algorithm for testing and reporting results of two commercial assays for HPV detection and typing in FFPE specimens, and describe HPV type distribution in pre-invasive and invasive cervical lesions in a state-based sample prior to HPV vaccine introduction.
url http://europepmc.org/articles/PMC3315505?pdf=render
work_keys_str_mv AT susanhariri hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT martinsteinau hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT allenrinas hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT juliawgargano hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT christinaludema hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT elizabethrunger hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT alicialcarter hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT kathylgrant hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT melaniebamberg hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT jamesemcdermott hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT lauriemarkowitz hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT noeltbrewer hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
AT jenniferssmith hpvgenotypesinhighgradecervicallesionsandinvasivecervicalcarcinomaasdetectedbytwocommercialdnaassaysnorthcarolina20012006
_version_ 1725011515617050624